United States Lipid Panel Testing Market Report, 2010 – 2020

1
United States Lipid Panel Testing Market Opportuni
ties, 2020
P h a r m a H e a l t h c a r e C o n
s u l t a n t s
2
R e s e a r c h M e t h o d o l o g y
US Lipid Panel Testing Market Opportunities,
2020
Secondary Research
Primary Research
Identifying Key Opinion Leaders Questionnaire
Design In-depth Interviews Coverage across
Value Chain market
Government websites Company annual reports,
white papers, investor presentations and
financial reports
Preliminary Data Mining
Qualitative and Quantitative research
Data Validation, Analysis and Interpretation
Data validation through Primary Secondary
outreach, data analysis and interpretation of
key findings
Market Estimation Forecasting ?Bottom-Up or
Top-down approach for Market size
estimation. ?Historical trend examination. ?Impact
analysis of drivers and challenges to market
growth. ?Statistical evaluation to develop the
actual forecast. CAGR (2015E-2020F) X 2
Pharmaion
2015E 2016F 2017F 2018F 2019F 2020F
3
T a b l e
o f C o n t e n t s
S. No. Contents Contents Contents
1. Lipid Panel Testing Overview Lipid Panel Testing Overview Lipid Panel Testing Overview
2. Research Methodology Research Methodology Research Methodology
3. Analyst View Analyst View Analyst View
4. Global Lipid Panel Testing Market Overview Global Lipid Panel Testing Market Overview Global Lipid Panel Testing Market Overview
5. United States Lipid Panel Testing Market Outlook United States Lipid Panel Testing Market Outlook United States Lipid Panel Testing Market Outlook
5.1. Market Size Forecast Market Size Forecast
5.1.1. By Value
5.2. Market Share Forecast Market Share Forecast
5.2.1. By Type
5.2.3. By End User
5.2.2. By Region
6. United Sates Lipid Panel Testing Service Market Outlook United Sates Lipid Panel Testing Service Market Outlook United Sates Lipid Panel Testing Service Market Outlook
6.1. Market Size Forecast Market Size Forecast
6.1.1. By Value
6.2. Market Share Forecast Market Share Forecast
6.2.1. By Type
6.2.2. By Service Provider
6.2.3 By Company
7. United Sates Lipid Panel Testing Device Market Outlook United Sates Lipid Panel Testing Device Market Outlook United Sates Lipid Panel Testing Device Market Outlook
7.1. Market Size Forecast Market Size Forecast
7.1.1. By Value
3
Pharmaion
4
T a b l e
o f C o n t e n t s
S. No. Contents Contents Contents Contents
7.2. Market Share Forecast Market Share Forecast Market Share Forecast
7.2.1. 7.2.1. By Type
7.2.2 7.2.2 By End User
8. Market Dynamics Market Dynamics Market Dynamics Market Dynamics
8.1.1 8.1.1 Drivers Drivers
8.1.2. 8.1.2. Challenges Challenges
9. Market Trends Developments Market Trends Developments Market Trends Developments Market Trends Developments
9.1. Online Blood Labs Online Blood Labs Online Blood Labs
9.2. Non invasive Cholesterol Testing Non invasive Cholesterol Testing Non invasive Cholesterol Testing
9.3 Inexpensive Lipid Panel Test Inexpensive Lipid Panel Test Inexpensive Lipid Panel Test
9.4 Mobile based SmartCARD Technology Mobile based SmartCARD Technology Mobile based SmartCARD Technology
9.5 Home Based Testing device Home Based Testing device Home Based Testing device
10. Policy Regulatory Landscape Policy Regulatory Landscape Policy Regulatory Landscape Policy Regulatory Landscape
11. United States Economic Profile United States Economic Profile United States Economic Profile United States Economic Profile
12. Competitive Landscape Competitive Landscape Competitive Landscape Competitive Landscape
12.1. Competition Benchmarking (Market Attractiveness) Competition Benchmarking (Market Attractiveness) Competition Benchmarking (Market Attractiveness)
12.2. Company Profiles Company Profiles Company Profiles
12.2.1. 12.2.1. Quest Diagnostics, Inc.
12.2.2 12.2.2 Alere Inc.
12.3.3 12.3.3 Polymer Technology Systems, Inc.
12.4.4 12.4.4 Roche Diagnostics Corporation
12.5.5 12.5.5 Siemens Healthcare Diagnostics, Inc.
3
Pharmaion
5
T a b l e
o f C o n t e n t s
S. No. Contents Contents Contents
12.2.6. Laboratory Corporation of America
12.2.7. Ortho-Clinical Diagnostics, Inc.
12.2.8. Abbott Laboratories
12.2.9. Danaher Corporation
12.2.10. Atherotech, Inc.
13. Strategic Recommendations Strategic Recommendations Strategic Recommendations
14. About Us Disclaimer About Us Disclaimer About Us Disclaimer
4
Pharmaion
6
I n d u s t r y B r i e f United States Lipid
Panel Testing Market to Cross US 6 billion by
2019 Growing consumer awareness coupled with
increasing prevalence of cholesterol related
diseases to drive United States lipid panel
testing market through 2020 According to
recently published Pharmaion report,United
States Lipid Panel Testing Market
Opportunities, 2010 - 2020, the lipid panel test
market in the United States is anticipated to
cross the US 6 billion mark by 2019. A wide
array of factors anticipated to influence the
growth of lipid panel testing market in the US
during forecast period include high incidence
rate of cardiovascular diseases, growing aging
population, rising prevalence of chronic
diseases and favorable reimbursement policies.
Moreover, increasing automation in laboratories
leading to higher sensitivity and faster test
results is forecast to further fuel the market of
lipid panel testing in the United States during
2015 - 2020. On the basis of services offered,
the market has been segmented into two broad
categories, namely, Lipid Panel Testing Services
and Lipid Panel Testing Devices. Among these
categories, lipid panel testing services segment
dominated the United States lipid panel testing
market in 2014. The segment is anticipated to
continue its dominance during forecast period as
well on account of the implementation of
Affordable Care Act, in 2010. Under this act,
cholesterol screenings and treatments were made
mandatory for all the citizens of the United
States. The largest market share in the United
States lipid panel testing market was captured by
the countrys South region, followed by the
West, Midwest and Northeast regions.
Growing number of initiatives by the government
and non-government organizations is resulting in
increasing awareness about cardiovascular
diseases. In 2011, Centres for Disease Control
and Prevention (CDC) launched an initiative
named as The Million Hearts with an aim to
prevent 1 million heart attacks and strokes by
2017. In 2015, an awareness steering committee
was set up by The National Forum for Heart
Disease Stroke Prevention, a non-profit
organization, which is involved in spreading
awareness regarding cholesterol related diseases
across the US. All these factors are expected to
have a positive impact on the countrys lipid
panel testing market through 2020. said Mr.
Karan Chechi, Research Director, with Pharmaion
Consultants, a research based global
pharmaceutical and healthcare consulting firm.
6
Pharmaion
7
L i p i d P a n e l T e s t i n g O v e r v i
e w
Lipids are defined as a group of fats or fat-like
substance which are an important constituents of
cells and sources of energy. The monitoring
and maintenance of appropriate levels of
these lipids is essential to live a healthy
life. Lipid Panel Testing (LPT) is the
diagnostic method used for analysis of
cholesterol level in the persons blood. It is
majorly recommended by the doctor as a part of
risk assessment to determine the possibility of
heart diseases in an individual. The results of
these tests plays an important role in deciding
the treatment depending upon the cholesterol
levels are at high risk or are at borderline.
Table 1 United States Government Recommended
Cut-off Levels for Cholesterol Testing
Test Acceptable (mg/dL) Borderline (mg/dL) High (mg/dL)
Children and Adolescents XXXX XXXX XXXX XXXX
Children and Adolescents XXXX XXXX XXXX XXXX
Young Adults XXXX XXXX XXXX XXXX
Young Adults XXXX XXXX XXXX XXXX
7
Pharmaion
8
S a m p l e
D a t a
- S n a p s h o t
United States Lipid Panel Testing Market Size, By
Region, By Value, 2010-2014 (USD Billion)
United States Lipid Panel Testing Market Size,
By Region, By Value, 2010-2020 (USD Billion)
18.0018.1018.2018.3018.4018.5018.6018.7018
.8018.9019.00
Northeas t
20.0020.1020.2020.3020.4020.5020.6020.7020
.8020.9021.00
Midwest
20.0020.1020.2020.3020.4020.5020.6020.7020
.8020.9021.00
West
30.0030.1030.2030.3030.4030.5030.6030.7030
.8030.9031.00
South
West Region
OWNERSHIP STRUCTURE, 2015 Public Share Holding,
34.00
Midwest Region
5.00
4.00
5.00
3.00
4.00
2.00
3.00
1.00
Shareholder Promoting Promoting Groups,
33.00
2.00
1.00
2010 2011 2012 2013 2014
2010 2011 2012 2013 2014
Non-Institutions, 33.00
Northeast Region
South Region
5.00
5.00
4.00
4.00
3.00
3.00
2.00
2.00
1.00
1.00
OWNERSHIP STRUCTURE (2015)
2010 2011 2012 2013 2014
2010 2011 2012
2013
2014
Institution al Ownershi
Others, 50.00
United States Lipid Panel Test Market Share, By
End User/Provider, By Value, 2010-2020F
58.0058.1058.2058.3058.4058.5058.6058.7058
.8058.9059.00
Hospital s
United States Lipid Panel Testing Market Size,
By Value, 2010-2020F (USD Billion)
Indepen dent Labs POLs Others
28.0028.1028.2028.3028.4028.5028.6028.7028
.8028.9029.00
12
11
10
9
8
9
7
8.00 8.10 8.20 8.30 8.40 8.50 8.60 8.70
8.80 8.90 9.00
5
4
3
2
1
2010 2011 2012 2013 2014 2015E 2016F
2017F 2018F 2019F 2020F
Pharmaion
2010 2011 2012 2013 2014
2015E2016F2017F2018F2019F2020F
9
Report Name United States Lipid Panel Testing
Market Opportunities, 2010 2020
R e p o r t O r d e r i n g
Report Price
License Type Price
Single User License 2500
Single User License Print 3000
Enterprise License 5000
To View Sample OR Purchase Report
9
Pharmaion
10
A b o u t U s D i s c l a i m e r About
Us Pharmaion is a research based management
consulting firm focused exclusively on Healthcare
Pharmaceutical industry. Pharmaions core
values are value, integrity and insight. Led by a
team of dynamic industry experts, Pharmaion
provides its customers with high value market
research and advisory services that helps them
identify new market opportunities, growth engines
and innovative ways to capture the market share.
As a result, Pharmaions clients lead rather than
follow market trends. Not bound by legacy,
Pharmaions cutting-edge research model leverages
its decades of research knowledge and an
increased use of technology as engines of
innovation to deliver unique research value.
Provided as an alternative to traditional market
research, Pharmaions reports do not just
deliver data and knowledge rather highlights the
insights in a more usable and interactive format
for its clients. Pharmaion is committed to
assisting customers worldwide with their unique
market research needs by providing them with
comprehensive, value-added solutions and
professional market intelligence services.
Pharmaion employs the industrys best-trained
industry Analysts and Consultants, which advises
and assists customers in meeting their full
service market research and consulting
requirements. Related Reports India Stem Cell
Market Opportunities, 2010-2020 Global Tissue
Engineered Medical Devices Market Opportunities,
2010-2020 Global Cervical Cancer Vaccine Market
Opportunities, 2010-2020 Disclaimer The contents
of this report are based on information generally
available to the public from sources believed to
be reliable. No representation is made that it
is timely, accurate or complete. Pharmaion
Consultants has taken due care and caution in
compilation of data as this has been obtained
from various sources including which it
considers reliable and first hand. However,
Pharmaion Consultants does not guarantee the
accuracy, adequacy or completeness of any
information and it is not responsible for any
errors or omissions or for the results obtained
from the use of such information and especially
states that it has no financial liability
whatsoever to the subscribers / users of this
report. The information herein, together with all
estimates and forecasts, can change without
notice. All the figures provided in this document
are indicative of relative market size and are
strictly for clients internal consumption.
Usage of the same for purpose other than internal
will require prior approval of Pharmaion
Consultants.
NORTH AMERICA Pharmaion Consultants LLC 708 3RD
Avenue, 6th Floor, New York, NY, United State,
10017 sales_at_pharmaion.com 1 646 360
1656 www.pharmaion.com
ASIA PACIFIC Pharmaion Consultants Pvt. Ltd. A
51, Sector 57, Noida, National Capital
Region, India - 201301 sales_at_pharmaion.com 91 -
120 - 452 3900 www.pharmaion.com
10 Pharmaion